Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study

BACKGROUND: Adjuvant chemotherapy with XELOX (capecitabine plus oxaliplatin) has been shown to be beneficial following resection of gastric cancer in South Korean, Chinese, and Taiwanese patients. This phase II study (J-CLASSIC-PII) was undertaken to evaluate the feasibility of XELOX in Japanese pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuse, Nozomu, Bando, Hideaki, Chin, Keisho, Ito, Seiji, Yoshikawa, Takaki, Tsuburaya, Akira, Terashima, Masanori, Kawashima, Yoshiyuki, Fukunaga, Tetsu, Gotoh, Masahiro, Emi, Yasunori, Yoshida, Kazuhiro, Oki, Eiji, Takahashi, Seiji, Kuriki, Hiroshi, Sato, Kumi, Sasako, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321693/
https://www.ncbi.nlm.nih.gov/pubmed/26956689
http://dx.doi.org/10.1007/s10120-016-0606-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321693/
https://www.ncbi.nlm.nih.gov/pubmed/26956689
http://dx.doi.org/10.1007/s10120-016-0606-4

Ejemplares similares